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ABSTRACT 
Basic helix-loop-helix (bHLH) proteins belong to a large family of transcription 
factors that are known to play important roles in cell proliferation, differentiation 
and oncogenesis. These proteins are structurally featured by a bHLH motif, 
which is responsible for protein dimerization and sequence-specific DNA binding 
(e.g., E-box). Recently we isolated a cDNA from a human liver library by a gene 
trapping method. Based on the Kozak rule, this cDNA encodes a protein with 
415 amino acids, which is hereafter designated as CCAF. The objective of this 
thesis is to establish the molecular mass of this protein and to test the hypothesis 
that CCAF is a transcriptional modulator involving the regulation of cell cycle 
events. 
To establish the molecular mass, CCAF was in vitro translated with TNT 
reticulocyte lysate and analyzed by autoradiography. Addition of the CCAF 
cDNA to the reaction mixture yielded a single product with a molecular weight of 
52 kDa. This mass is consistent with the estimated weight and suggests that the 
Kozak favorable sequence indeed harbors the codon for translation initiation. In 
order to determine whether CCAF undergoes posttranslational modifications, 
immunochemical experiments were performed. An antibody was raised against 
a peptide derived from CCAF and subjected to affinity chromatography. This 
antibody detected a 52-kDa protein in the CCAF cDNA transfected cells but not 
in the control cells. These results further support the notion that the functional 
CCAF is a 52-kDa protein and undergoes little post-translational modifications. 
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To determine the expression of CCAF in different cell growing states, OLD cells 
derived from colon carcinomas were seeded at different densities. Likewise, this 
antibody detected the 52-kDa protein in the cells plated at all densities. 
However, proliferating cells expressed higher levels (-3-5 folds) than the 
quiescent cells. These studies were further extended to human colon 
carcinomas. Both Northern and Western blotting analyses detected abundant 
expression of CCAF in the carcinomas but not in the nearby normal tissues. 
These findings suggest that CCAF involves the regulation of cell cycle events 
and contributes to the oncogenic pathogenesis. 
To determine the activity of CCAF in transcription regulation, transient 
cotransfection experiments were conducted with an E-box reporter. CCAF alone 
caused little change on the reporter enzyme activity. However, CCAF 
antagonized by 30% the transactivation activity conferred by E4 7, a bHLH protein 
that is known to transactivate E-box reporter. The antagonism on E47-mediated 
transactivation activity and the differential expression relating to cell growing and 
oncogenic states support the hypothesis that CCAF is a transcriptional modulator 
that involves the regulation of cell cycle events and plays a role in oncogenic 
pathology. 
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ABSTRACT 
Basic helix-loop-helix (bHLH) proteins belong to a large family of transcription 
factors that are known to play important roles in cell proliferation, differentiation 
and oncogenesis. These proteins are structurally featured by a bHLH motif, 
which is responsible for protein dimerization and sequence-specific DNA binding 
(e.g., E-box). Recently we isolated a cDNA from a human liver library by a gene 
trapping method. Based on the Kozak rule, this cDNA encodes a protein with 
415 amino acids, which is hereafter designated as CCAF. The objective of this 
thesis is to establish the molecular mass of this protein and to test the hypothesis 
that CCAF is a transcriptional modulator involving the regulation of cell cycle 
events. 
To establish the molecular mass, CCAF was in vitro translated with TNT 
reticulocyte lysate and analyzed by autoradiography. Addition of the CCAF 
cDNA to the reaction mixture yielded a single product with a molecular weight of 
52 kDa. This mass is consistent with the estimated weight and suggests that the 
Kozak favorable sequence indeed harbors the codon for translation initiation. In 
order to determine whether CCAF undergoes posttranslational modifications, 
immunochemical experiments were performed. An antibody was raised against 
a peptide derived from CCAF and subjected to affinity chromatography. This 
antibody detected a 52-kDa protein in the CCAF cDNA transfected cells but not 
in the control cells. These results further support the notion that the functional 
CCAF is a 52-kDa protein and undergoes little post-translational modifications. 
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To determine the expression of CCAF in different cell growing states, OLD cells 
derived from colon carcinomas were seeded at different densities. Likewise, this 
antibody detected the 52-kDa protein in the cells plated at all densities. 
However, proliferating cells expressed higher levels (-3-5 folds) than the 
quiescent cells. These studies were further extended to human colon 
carcinomas. Both Northern and Western blotting analyses detected abundant 
expression of CCAF in the carcinomas but not in the nearby normal tissues. 
These findings suggest that CCAF involves the regulation of cell cycle events 
and contributes to the oncogenic pathogenesis. 
To determine the activity of CCAF in transcription regulation, transient 
cotransfection experiments were conducted with an E-box reporter. CCAF alone 
caused little change on the reporter enzyme activity. However, CCAF 
antagonized by 30% the transactivation activity conferred by E47, a bHLH protein 
that is known to transactivate E-box reporter. The antagonism on E4 ?-mediated 
transactivation activity and the differential expression relating to cell growing and 
oncogenic states support the hypothesis that CCAF is a transcriptional modulator 
that involves the regulation of cell cycle events and plays a role in oncogenic 
pathology. 
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INTRODUCTION 
Transcription factors are proteins that initiate and modulate transcription rate by 
interacting with specific DNA recognition sequences in the target genes. As 
shown in Fig. 1, these DNA-binding transcription factors are structurally classified 
into four major classes: Helix-turn-helix homeodomain (e.g. PBX1 ), C2H2 zinc 
finger (e.g., Sp1 ), Helix-loop-helix (e.g., c-myc) and Leucine zipper (e.g. , c-fos 
and c-jun). Many other transcription regulators fall into none of these classes. 
Therefore, a better classification system needs to be developed. 
NH1 
Helix-turn-helix 
=1 ~: .. 
-~ r~: 
4: ~ ' /,. .. ,, 
NH, NH 1 
Helix-loop-helix 
Zinc finger 
Leucine zipper 
Figure 1. Classification of transcription factors 
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Basic helix-loop-helix (bHLH) proteins belong to a family of well-characterized 
transcription factors. They play important roles in the control of cell proliferation 
and differentiation that are involved in organ development and oncogenesis. For 
example, they function in myogenesis (Myo0/E47), neurogenesis (NeuroD, 
Achaete-scute/Oaughterless), tumorgenesis (Myc/Max) and sex determination 
(E12/Da/ESC) (Little et al., 1998). In addition, these proteins are also involved in 
immunoglobulin gene regulation (TFEC/TFE3) (Zhao et al., 1993), phospholipid 
and pigment metabolism (lno2/Delila) (Nikoloff et al., 1992, Goodrich et al., 
1992), and xenobiotic response (AHR/ARNT) (Hirose et al., 1996). 
I. Common Features of bHLH Proteins 
1. Structural characteristics of bHLH proteins 
bHLH proteins are distinguished by their bHLH domain, which was first identified 
in an immunoglobulin enhancer-binding polypeptide and several other proteins 
(e.g. Daughterless, MyoD and myc) (Murre et al., 1989). The bHLH domain is 
divided into two functional subdomains: a Helix-loop-helix (HLH) subdomain and 
an adjacent basic region. The HLH subdomain consists of two short amphipathic 
a-helices separated by a non-conserved loop with various lengths and primarily 
mediates the dimerization between HLH proteins (Voronova et al., 1990). The 
basic region consists of a cluster of 10-20 amino acids rich in lysine and arginine 
residues and is responsible for sequence-specific DNA binding (Burley, 1994 ). 
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In addition to the bHLH domain, some proteins contain other structures that are 
functionally important (Fig. 2). The myc oncoproteins contain a leucine zipper 
(LZ) motif that is responsible for dimerization (Penn et al., 1990). Drosophila 
hairy, E(spl) and the mammalian homologues (e.g., HES) contain an orange 
domain, a Drosophila C-terminal binding protein (dCtBP) motif (PLSLV) and a 
Groucho motif (WRPW). The orange domain mediates transcription repression 
(Dawson et al., 1995). PLSLV and WRPW motifs mediate the recruitment of 
transcription corepressors dCtBP and Groucho, respectively (Poortinga et al., 
1998, Sewalt et al., 1999, Zhang et al., 1999). A group of the bHLH proteins 
(e.g., AHR and ARNT) contains a PAS domain that is responsible for 
dimerization between PAS proteins, xenobiotic binding and interaction with non-
PAS proteins (Lindebro et al., 1995, Gradin et al., 1996). A conserved domain C 
in E proteins is also required for in vivo dimerization (Goldfarb et al., 1998). 
bHLH 
MyoD I I 
bHLH Leucine zipper 
myc I I I 
bHLH Orange dCtBP Groucho 
HES I I I I 11 111 
bHLH PAS 
ARNT I I I 
c bHLH 
E47 1111 I 
Figure 2. Functional domains of bHLH proteins 
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2. Classification of bHLH proteins 
bHLH proteins are widely distributed in mammalian species, Drosophila, yeast 
and plants. More than 250 bHLH proteins have been identified in mammals and 
this number is increasingly expanding. Three systems based on different criteria 
are currently used for the classification of these proteins. Each of these will be 
discussed individually. 
2. 1 Based on tissue distribution and dimerization 
In this classification system, bHLH proteins in mammals are grouped into two 
classes based on their expression pattern (Table 1 ). Class I, also known as E-
protein family, consists of bHLH proteins encoded by E2A, HEB and E2-2 genes 
(Little et al., 1998). E2A encodes E12 and E47, which are produced by 
alternative splicing (Sun et al., 1991 ). Class I proteins are ubiquitously 
expressed and capable of forming transcriptionally active homo and/or 
heterodimers. Class II proteins display a tissue- or cell-restricted expression 
pattern. For example, myogenic bHLH proteins (e.g., MyoD) present specifically 
in muscle cell lineage while neurogenic bHLH proteins (e.g., NeuroD) present 
mostly in neural system. Class II proteins can exist as homodimers, but the 
active form is predominantly the heterodimers formed with class I proteins (Murre 
etal., 1994, Little et al., 1998). 
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Class 
II 
Table 1. Classification based on tissue distribution and dimerization 
Example Tissue distribution Homodimer Heterodimer 
E12, E47, HEB, 
E2A Universal 
MyoD and NeuroD Restricted 
Yes Yes 
No activity Yes 
2. 2 Based on structural domains 
In this classification system, bHLH proteins are grouped into three classes based 
on their structural domains (Table 2). Class I includes bHLH proteins (e.g., E47 
and MyoD) that have a basic region adjacent to the N-terminus of the HLH 
domain. Class II includes bHLHZ proteins (e.g., myc and Max) that contain an 
additional LZ dimerization domain immediately C-terminal to the bHLH domain. 
Class Ill includes HLH proteins that lack the DNA-binding domain due to the loss 
of the basic region (e.g., Id). These proteins act as negative regulators by 
effectively forming inactive, non-DNA-binding heterodimers with other bHLH 
proteins. Although mammalian homologues of E(spl) such as HES have an 
intact basic region, they also belong to this class because there is a proline 
residue in their basic region, leading to a preference for an N-box instead of an 
E-box site. The binding to the N-box results in transcription repression. 
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Table 2. Classification based on structural features 
Class Family Proteins 
I, bHLH proteins Ubiquitous E12/E47, HEB 
Neurogenic NueroD, MATH and Mash 
Myogenic MyoD, Myogenin, Myf5, MRF4 
Haemato- poeitic Ly1, Ly2, Tal1, Tal2, Hen1 and Hen2 
Others Arnt1, Arnt2 and Ah receptor 
II, bHLHZ proteins Myc c-Myc, N-Myc, L-Myc and v-Myc 
Max Max 
Mad Mad1, Mxi1, Mad3 and Mad4 
AP4 AP4 
USF USF1 and USF2 
lg enhancer binding TFE3, TFEB, TFEC 
Ill, HLH proteins Mammalian Hes1, Hes2, Hes3, Hes4 and Hes5 
homologues of (E(spl)) 
Id Id 1, ld2, ld3, and ld4 
2.3 Based on evolutionary relationship 
This classification system was recommended recently based on the evolutionary 
relationship among bHLH proteins (Atchley et al., 1997). In this classification, the 
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phylogenetic analysis of amino acid sequences is used to describe the patterns 
of evolutionary change within the motif and define the evolutionary lineages. 
These evolutionary lineages are well-known functional groups of proteins that 
can be further arranged into five classes based on the DNA binding (E-box), the 
amino acid patterns in the basic region, and the presence or absence of a LZ 
(Table 3). The hypothesized ancestral amino acid sequence for the bHLH 
transcription family is given together with the ancestral sequences of the 
subclasses. 
Table 3 Classification of bHLH proteins based on evolutionary relationship 
Class Protein 
A 
B 
c 
D 
? 
E12, MyoD, NeuroD 
Myc, ARNT, HES 
sim 
Id 
AP-4 
E-box 
CAGCTG 
CACGTG 
CACGTG 
No 
CAGCTG 
LZ aa pattern in basic region 
No 
Yes/No 
No 
No 
Yes 
5-8-13 (xRx) 
5-8-13 (BxR) 
Not consistent 
No basic region 
5-8-13 (xKx) 
Note: aa, amino acid; 5-8-13, aa position; x, any aa; R, Arginine; 
B, any basic aa; K, lysine. 
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3. Transcription regulation of bHLH proteins 
3. 1 Dimerization 
bHLH proteins act as transcription modulators, and the dimerization is the 
prerequisite for their function. For some bHLH proteins such as the ubiquitously 
expressed E protein family (e.g., E12, E47), the active forms are either homo- or 
heterodimers. Other bHLH proteins such as the myogenic MyoD family can exist 
as homodimers, but the active dimers are the heterodimers. Consistent with this 
finding, the antisense inhibition on E12 expression blocks the muscle-specific 
gene expression induced by MyoD (French et al., 1991 ). bHLH proteins exhibit 
different biological functions by heterodimerizing with different partners. For 
example, heterodimerization of Da with members of the Achaete-Scute class 
leads to the formation of neuronal precursors (Cabrera et al., 1991 ). On the 
other hand, heterodimerization of Da with Atonal protein leads to the formation of 
different, nonoverlapping sense organs and photoreceptors (Jarman et al., 1994 ). 
3. 2 DNA binding 
After dimerization, bHLH proteins usually bind to the cis-acting DNA elements 
present in the target genes, resulting in the change of the gene expression. 
These DNA elements contain core sequences CANNTG or CACNAG. CANNTG, 
commonly known as the E-box, was first identified in the immunoglobulin heavy-
chain (lgH) intronic enhancer and has been found in a large number of 
pancreatic-, lymphoid-, and muscle-specific promoter and enhancer elements 
(Little et al., 1998). CACNAG, commonly referred to as N-box, is present in the 
10 
promoter of genes such as HES gene. Most bHLH proteins (e.g., MyoD, E12) 
bind as dimers to E-box (Hsu et al, 1994), while some bHLH proteins (e.g., Hairy 
and HES) prefer to binding to the N-box (Dawson et al., 1995). The binding 
preference is specified by the sequence in the basic region of bHLH proteins. 
Generally, the praline-containing basic region has a higher affinity toward the N-
box, whereas the basic region without a praline preferentially recognizes the E-
box. Some bHLH heterodimers recognize different core DNA sequences rather 
than E- or N-box. For example, the AHR-ARNT complex usually binds to the 
dioxin response element TNGCGTG (Bacsi et al., 1995). 
3. 3 Transcriptional regulation 
Binding to specific DNA elements by bHLH proteins leads to transcriptional 
activation or repression. MyoD and its related myogenic bHLH proteins, for 
example, bind to the E-box and activate transcription of myogenic genes 
(Weintraub et al., 1991 ). Drosophila Hairy and its related protein E(spl) and 
HES, however, bind to the N-box and inhibit the transcription of neurogenic 
genes (Dawson et al., 1995). This transcription repression process is outlined in 
Fig. 3. The N-box binding of transcription repressive proteins such as Hairy 
results in an orange domain-mediated repression on the E-box binding proteins 
such as Da/Scute. This binding also leads to a recruitment of Groucho, which is 
a transcription corepressor. Other than the N-box binding, Drosophila Hairy and 
its related proteins have been shown to form non-functional heterodimers with E-
box binding bHLH transactivation proteins (Sasai et al., 1992). Therefore, 
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transcriptional repression of bHLH proteins is achieved in two distinct manners, 
binding to the N-box and/or titrating other bHLH proteins. 
othcn 
activator• 
------
x 
Figure 3. Model for N-box binding mediated transcription repression 
(Dawson et al. , 1995) 
Both transcription activation and repression mediated by bHLH proteins are 
essential for organ development. Lack of either mechanisms results in 
developmental defects. For example, Mash1 promotes the neuronal 
differentiation. The absence of Mash1 in mice results in death at birth 
accompanied by the loss of olfactory and autonomic neurons (Guillemot et al., 
1993). HES proteins, however, suppress the neuronal differentiation. The 
absence of HES proteins (e.g ., HES1) accelerates neuronal differentiation, 
resulting in severe defects such as anencephaly and eye anomalies (Ishibashi et 
al. , 1995). 
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4. Other features of bHLH proteins 
In addition to the characteristics described above, bHLH proteins also have other 
important properties in the organ developmental processes. Some bHLH 
proteins compensate functionally for each other and are subjected to auto- and 
cross-regulation. For example: 1. Myf5, a myogenic bHLH protein, was initially 
found indispensable for normal rib cage development. In a later experiment, 
however, the insertion of the myogenin gene, a homologue of myf5, into the myf5 
locus (simultaneously disrupting myf5 function) was found to give rise to mice 
with a normal rib cage (Wang, et al., 1996). 2. In vertebrate myogenesis, MyoD, 
Myf5 and myogenin all up-regulate their own expression. They are also able to 
regulate the expression of others (Fig. 4 ). MyoD is required for the expression of 
myogenin. Myf5 induces MyoD, and Id is inactivated by MyoD. A similar 
complex network also occurs in bHLH proteins involved in neurogenesis and sex 
determination. 
V crtcbutc 
myogcncsis ~ 
precursor 
El2 or E47 fMvyogenin ~ muscle ) !----.,._ specific T MRF4 genes 
Id proteins 
?Hes proteins 
determined 
myoblast 
differentiated 
myocytc 
Figure 4. Networks of bHLH proteins involved in vertebrate myogenesis 
(Little et al., 1998) 
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II. Significance of bHLH Proteins in Oncogenesis 
The bHLH proteins play important roles in the control of cellular proliferation and 
differentiation in various lineages, from invertebrates to mammals. An imbalance 
between the cell proliferation and differentiation caused by bHLH proteins may 
have oncogenic significance. Generally, proliferation-promoting action is 
oncogenic, while differentiation-promoting action is tumor-suppressing. Myc 
proteins, for example, are known to promote cell proliferation and inhibit 
differentiation (Penn et al., 1990, Chin et al., 1995). Several members of the myc 
family in cooperation with an activated ras oncogene have transformed primary 
rat embryonic cells in culture (Land et al., 1986). Transgenic mice with enforced 
c-myc expression also exhibit a significantly higher incidence of malignancy than 
control mice (Davis et al., 1993). 
E proteins, on the other hand, promote cell differentiation. The E2A-null mice 
(the absence of E2A protein) develop T-cell tumors (Yan et al., 1997). Tal1, a 
putative oncogene originally identified through its involvement in T-cell acute 
lymphoblastic leukemia {T-ALL), does not form homodimers but dimerize tightly 
with E proteins. Such heterodimers confer little transactivation activity (Steven et 
al., 1998). Sequestration of E proteins by Tal1 oncoprotein likely results in cell 
de-differentiation and induces oncogenic pathogenesis. 
14 
The oncogenic mechanisms by bHLH proteins remain to be established. The 
deregulation of gene expression by these proteins plays a major role in tumor 
formation. For example, the p53 tumor suppressor gene contains an essential 
CACGTG motif within the promoter region. The ectopic c-myc can specifically 
bind to this motif and activate the expression of the mutant p53, leading to 
oncogenic transformation (Popescu et al., 1998). Other than the gene regulation, 
a protein-protein interaction is also found responsible for the oncogenesis of 
some bHLH proteins. For example, in the presence of overexpressed LM01, the 
enforced expression of an amino-terminal truncated Tal1, which lacks the 
transactivation domain, leads to aggressive T-cell malignancies in transgenic 
mice (Aplan et al., 1993). In this case, Tal1 is not acting by transactivation of the 
target genes, but acting through a protein-protein interaction. 
Ill. Statement of Purpose 
A full-length cDNA was recently isolated in our lab from a human liver library by a 
gene trapping method. The sequence alignment reveals that this cDNA encodes 
a protein highly similar to bHLH proteins such as human DEC1 (-92%), and rat 
SHARP (-80%) and mouse strate 8, particularly in the region encoding functional 
structures such as bHLH domain (Fig. 5). DEC1 is a Bt2cAMP inducible bHLH 
protein that may function as a transcription regulator in chondrogenesis (Shen et 
al., 1997). SHARP proteins are mammalian E(spl) and hairy-related bHLH 
proteins that play essential roles in neurogenesis (Rossner et al., 1997). 
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< basic >< helix 1 >< loop > < helix 2 > 
CCAF ETYKLAAPAHR- -EKEERDRINECIAQLKDLLPEHLKL TTLGHLEKAWLEL Tl KHVKAL T 
DEC1 ETYKL - - P- HRLIEKKRRDRINECIAQLKDLLPEHLKL TTLGHLEKAWLEL TLKHVKAL T 
SHARP ETYKL- - P- HRLIEKKRRDRINECIAQLKDLLPEHLKL TTLGHLEKAWLELTLKHVKAL T 
Figure 5. Comparison of CCAF bHLH domain with other bHLH proteins 
Based on the Kozak rule, this cDNA encodes a 415 amino acid protein termed 
colon cancer-associated factor (CCAF), from the first starting AUG codon, which 
is harbored by a Kozak favorable sequence. The purpose of this thesis is to 
determine that the translation is indeed started from the first AUG codon 
and to establish the molecular weight of CCAF. CCAF was in vitro translated 
with TNT reticulocyte lysate. The molecular weight of the synthesized CCAF was 
determined via SDS-polyacrylamide gel electrophoresis (SOS-PAGE) followed by 
autoradiography. In order to further determine whether CCAF undergoes 
posttranslational modifications, in vivo COS? cell transient transfection was 
performed. The CCAF cDNA-transfected cell lysates were subjected to SOS-
PAGE and then immunochemically detected by an antibody, which was raised 
against a peptide derived from CCAF and purified via affinity chromatography. 
This antibody was also used to determine the cellular localization of CCAF. 
bHLH proteins are known to play important roles in the control of cellular 
proliferation and differentiation. The experiments in this thesis were designed 
to determine the expression of CCAF in different cell growth states. OLD 
cells derived from colon carcinomas were seeded at different densities, inducing 
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different cell growth states. The CCAF expression in each state was detected by 
the antibody prepared against CCAF. OLD cells were also seeded at a certain 
density, and after reaching confluence, cells were maintained in the same 
medium or changed to 0.25% medium for 4 additional days. The expression of 
CCAF was detected at each day point by the same antibody. 
The deregulated or ectopic expression of some bHLH proteins (e.g., myc and 
Tal1) is known closely related to the oncogenic pathogenesis. The experiments 
in this thesis were designed to determine the expression of CCAF in human 
carcinomas and the normal nearby tissues. Northern blot probed with 
radioactive-labeled CCAF cDNA was performed to detect the CCAF gene 
expression in cancer and nearby normal tissues. The same antibody against 
CCAF was also used to detect the CCAF protein expression in these tissues. 
In addition to the bHLH domain, CCAF contains an orange domain and a 
modified dCtBP motif (PLSLV), which are present in the transcription repressive 
bHLH proteins such as Drosophila Hairy and mammalian HES (Fig. 6). The 
purpose of the studies in this thesis was to test the hypothesis that CCAF 
is a transcription modulator. To determine the activity of CCAF in transcription 
regulation, transient cotransfection assays were conducted with an E-box 
reporter in COS? cells. The transcriptional modulation activity of CCAF was 
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determined by measuring the E-box mediated enzyme expression with a dual-
luciferase assay. 
bHLH Orange dCtBP 
CCAF I I I 11 
bHLH Orange dCtBP Groucho 
Hairy I I I 11 111 
Figure 6. Function domains of CCAF and bHLH repression protein 
Overall, the objectives of this thesis are to establish the molecular mass of this 
protein and to test the hypothesis that CCAF is a transcriptional modulator 
involving the regulation of cell cycle events. The results in this thesis will provide 
a fundamental basis for further characterization of CCAF such as the protein-
protein interaction and transactivation activity, and therefore expand our 
understanding of the physiological and pathological significance of bHLH 
proteins. 
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Table 4. Abbreviation of bHLH proteins 
Ah 
AP4 
Arnt 
Da 
E-box 
E(spl) 
HEB 
HES 
Id 
Hen 
Ly1 
Mad 
Mash 
Max 
Maxi1 
MRF4 
Myf 
MyoD 
N-box 
Tai 
TFE3 
TFEB 
TFEC 
USF 
aryl hydrocarbon 
activator protein 4 
Ah receptor nuclear translocation protein 
Daughterless protein (Drosophila) 
Ephrussi box, consensus sequence CANNTG 
Enhancer of split protein (Drosophila) 
Hela Ebox binding factor 
Hairy- and Enhancer of split-related mammalian proteins 
inhibitor of differentiation protein 
Helix-loop-helix encoded in neuroblastoma protein 
lymphoid leukaemia protein 
Max-associated dimer protein 
mammalian Achaete-Scute homologue protein 
Myc-associated x protein 
Max interactor 1 protein 
muscle regulatory factor 1 
myogenic factor 
myogenic determination factor 
consensus sequence CACNAG 
T cell acute leukemia protein 
transcription factor E3 binding 
transcription factor enhancer binding 
transcription factor C 
upstream stimulatory factor 
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MATERIALS AND METHODS 
Plasmid construction 
E4 7 and E-box-luciferase reporter plasmids were kindly provided by Dr. Jinming 
Chiu (Ohio State University, Ohio). CCAF cDNA was cloned from human liver 
cDNA library in our lab with a Gene Trapping kit (GIBCO BRL, Grand Island, 
NY). The plasmid DNA of CCAF was isolated with a QIAprep Spin Minip.rep kit 
(QIAGEN Inc., Valencia, CA). The partial sequencing was determined with a 
Sequi Therm EXCEL II DNA Sequencing Kit (Epicentre Technologies, Madison, 
WI) by T? or SP6 primer. The entire sequence was characterized by Genemed 
Synthesis Inc. (South San Franciscan, CA). 
Transformation and endotoxin-free plasmid extraction 
The plasmid was incubated with JM109 bacteria for 20 min on ice, followed by a 
heat-shock for 45-50 sec at exactly 42°C in a water bath. After 1.5 hr of 
incubation in SOC medium at 37°C with shaking, the transformed bacteria grew 
overnight at 37°C in 1.5 % agar plates (100 µg/ml ampicilin). Positive colonies 
with E4 7 or E-box-luciferase cDNA insertion were identified with restriction 
enzymes and analyzed by 1 % agarose gel electrophoresis. 
CCAF, E4 7 and E-box-luciferase reporter plasmids for in vitro translation and in 
vivo transfection were isolated with an EndoFree Plasmid Maxi kit (QIAGEN, 
VALENCIA, CA). The individual colonies were incubated in 2-5 ml selective LB 
medium (100 µg/ml ampicilin) at 37°C for 8 hr with vigorous shaking (-300 rpm). 
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They were then diluted at 1: 1000 into 100 ml selective LB medium and grew 
under the same conditions for 12-16 hr. Bacteria were harvested by 
centrifugation for 10 min at 4 °C, 6000 rpm (JOUAN, Winchester, VA), and 
plasmid DNAs were isolated according to the instruction of the manufacturer. 
The concentration of plasmid DNA was determined by measuring optical density 
(OD) with an UV spectrometer at a wavelength of 260 nm (1 OD = 50 µg/ml 
plasmid DNA). 
In vitro translation 
CCAF was in vitro synthesized via a TNT-coupled reticulocyte lysate system 
(PROMEGA, Madison, WI) following the instruction by the manufacturer. Briefly, 
CCAF plasmids (0.5 µg) were added to 25 µI of reaction mixture containing 
reticulocyte lysate, amino acid mixture without methionine, 35S-labeled 
methionine and SP6 polymerase. After 60 min of incubation at 30°C, the 
reaction mixture was chased by adding 625 µM unlabelled methionine (0.5 µI) for 
30 min. To determine the molecular weight of the synthesized CCAF, the 
mixture (5 µI) was denatured in 20 µI of 1X SOS-PAGE sample buffer (31.25 mM 
Tris-HCI at pH6.8, 5% glycerol, 0.025% bromophenol blue and 2.5% 2-
mercaptoethanol) at 80°C for 5 min and size-separated via SOS-PAGE. The gel 
was washed with solution A (50% methanol and 10% acetic acid) for 30 min and 
then solution B (7% methanol, 7% acetic acid and 1 % glycerol) for 5 min. CCAF 
was detected by exposing the vacuum-dried gel to an X-ray film. 
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Cell culture 
The COS? cell line was provided by Dr. Hixon (Rhode Island Hospital, RI). The 
OLD colon cancer cell line was provided by Dr. Chichester (University of Rhode 
Island, RI). Unless otherwise indicted, all the reagents for cell culture were 
purchased from GIBCOL BRL (Grand Island, NY). COS? cells grow in 
Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal calf 
serum (FCS), 1 mM pyruvate, 1x nonessential amino acids, 2 mM L-glutamine 
and 50 µg/ml gentamicin. OLD cells grow in RPMI 1640 medium supplemented 
with 10% FCS, 2 mM L-glutamine, 1 x nonessential amino acids and 25 µg/ml 
gentamicin. Both cell lines were maintained at 37°C, 5% C02, 95% 0 2 and 100% 
humidity. After reaching confluence, cells were split by digestion with 0.5% 
trypsine for 4 to 5 min at 37°C. The number of cells was counted via a 
hemotocytemeter under a reverse-controversial microscopy after 0.4% typan 
blue staining. 
Transient transfection 
CCAF endotoxin-free plasmids were transiently transfected into COS? cells via 
lipofectamine, a cationic lipid as described by the manufacturer (Gibco BRL 
Gaithersburg, MD). COS? cells were seeded in 12-well plates (CORNING, 
Corning, NY) in RPMI 1640 medium supplemented with 10% FCS at a density of 
1x105 cells per well. On day 2, cells achieved 60-80% confluence. Prior to 
transfection, plasmid DNA (0.2 or 0.4 µg) was mixed with lipofectamine (2 µI) in 
80 µI of transfection DMEM (without FCS and gentamicin) at room temperature 
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for 45 min, and then diluted to 320 ml with the same medium. Cells were 
exposed to the transfection mixture at room temperature for 4 to 5 hr, and 
switched to normal DMEM. The transfected cells were incubated for an 
additional 48 hr and harvested in lysis buffer (1 % SOS in Tris-HCI buffer, pH 6.8, 
150 µI per well). Protein concentration of cell lysate was assayed with a BCA 
micro protein assay kit (PIERCE, Rockford, IL) at a wavelength of 570 nm via a 
MRX microplate reader (DYNEX, Chantily, VA). A dilution of sample at 1 :40 was 
usually required before performing the protein assay. 
Cotransfection and dual luciferase assay 
To determine the activity of CCAF on gene transcription, E-box-luciferase 
reporter plasmids (160 ng) were cotransfected with CCAF plasmids (100 ng) to 
COS? cells in the presence of lipofectamine following the same procedure as 
described above. E47 plasmids (100 ng) were transfected as a positive control. 
pRL-TK plasmids (32 ng, Promega, Madison, WI) encoding Renilla luciferase 
served as a background control. Transfected cells were incubated for 48 hr, 
rinsed with sodium phosphate buffer twice and lysed in 250 µI of passive lysis 
buffer at room temperature for 15 min on a rocking platform. The reporter 
enzyme activities were determined with a Dual-luciferase Reporter Assay System 
via a TD-20/20 luminometer (Promega, Maison, WI). The assay program was 
set up to a 2-second delay and a 10-second integration. This assay system 
contains two substrates, which give rise to two kinds of luminescence signals. 
The Firefly luminescence signal , which represented the reporter gene activity, 
23 
was initiated by mixing cell lysate (20 µI) with substrate Luciferase Assay 
Reagent II (LARll, 100 µI). The Renil/a luminescence signal, which represented 
the background luciferase activity, was detected by sequentially adding Stop & 
Glu reagent (100 µI) to the same mixture. The induction of reporter enzyme 
activity was designated as the ratio of Firefly luminescence signal over the 
Renilla luminescence signal. In this experiment, each group was tested in 
triplicate and repeated once. 
SOS-Polyacrylamide gel electrophoresis 
SOS-PAGE was conducted with Minimum Gel Apparatus (BioRad, Hercules, 
CA). The gel contained two parts: 4% polyacrylamide staking gel (0.25 M Tris-
HCI, pH6.8, 1 % SOS) on the top and 7.5% polyacrylamide separating gel (0.375 
M Tris-HCI, pH8.8, 1 % SOS) at the bottom. Cell lysate containing 15 µg protein 
was denatured in equal volume of 2 x SOS-PAGE sample buffer (62.5 mM Tris-
HCI at pH 6.8, 2% SOS, 10% glycerol, 0.025% bromphenol blue, 5% 2-
mercptoethanol) at 95°C for 5 min and centrifuged at 11,000 rpm for 10 min. The 
supernatant was separated in the stacking gel at 43 V, 16 mA for about 30 min 
and in the separating gel at 120 V, 26 mA for about 1.5 hr. 
Coomassie blue assay 
Transfected cell lysate was subjected to SOS-PAGE as described previously. 
The gel was stained for half an hour with 0.1 % Coomassie blue R-250 in a 
fixative solution (40% MeOH, 10% HOAc), destained with 40% MeOH/10% 
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HOAc (1 to 3 hr) to remove the background and then vacuum-dried on a gel 
drier. The expression pattern of total proteins in transfected COS? cells was 
visualized by Coomassie blue staining. 
Antibody purification 
A polyclonal antibody specific to the peptide (CSQALKPIPPLNLETKD) derived 
from C-terminus of CCAF was raised in New Zealand White rabbits in our lab. 
To diminish the nonspecific binding, the antibody was purified by immunoaffinity 
chromatography. This was conducted as described by Harlow and Lane (Harlow 
et al, 1988). First, the peptide (1 mg) was covalently coupled to 2 ml of SulfoLink 
gel (PIERCE, Rockford, IL) via incubation at room temperature for 30 min in a 
PD-10 column (Pharmacia Biotech, Sweden). 50 mM cysteine (2 ml) was then 
added to block the nonspecific binding sites. Prior to applying the antiserum, this 
antigen-coupled gel column was sequentially pretreated with 20 ml of Tris 
(pH7.5), 20 ml of 100 mM glycine (pH 2.5) and 20 ml of 100 mM triethylamine 
(pH11.5, fresh). The antiserum (5 ml) was 1 :1 diluted with 10 mM Tris (pH7.5) 
and repetitively applied to the column three times to ensure the complete binding. 
The column was washed with 40 ml of 10 mM Tris (pH7.5) followed by 40 ml of 
500 mM NaCl in 10 mM Tris (pH7.5). The antigen specific antibody was then 
eluted from the column with 20 ml of 100 mM glycine (pH2.5), and collected in a 
tube containing 5 ml of 1 M Tris-HCI (pH 8.0). The elution was dialyzed in a tu bin 
against PBS (containing 0.02% sodium azide) at 4°C overnight with stirring, and 
then aliquoted and stored at -20°C. 
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Western immunoblotting 
The transfected cell lysate was subjected to SOS-PAGE as described previously. 
For immunoblot analysis, the separated proteins were transferred to a 
nitrocellulose membrane by electroblotting for 1 hr 20 min at 36 V, 150 mA in 
transfer buffer (25 mM Tris, 190 mM glycine, and 20% methanol). The 
membrane was then blocked in 5% non-fat dry milk in TBST (10 mM Tris 8.0, 
150 mM NaCl, 0.05% Tween 20) for half an hour, and probed by the purified 
antibody at 1: 100 dilution for 1 hr. The membrane was then washed three times 
(5-10 min/each) with TBST, and incubated with an alkaline phosphatase-
conjugated anti-rabbit lgG at 1 :5000 dilution for at least 0.5 hr. lmmunoblots 
were developed by color precipitation catalyzed by phosphatase in the presence 
of chromogenic substrates, 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and 
Nitro blue tetrazolium (NBT) in alkline phosphatase buffer (0.1 M Tris, o.1 M NaCl, 
and 5mM MgCl2, pH9.5). 
CCAF expression at different cell growth states 
In this experiment, different cell growth states were induced by three individual 
methods: ( 1) OLD colon cancer cells were seeded in 12-well plates at various 
densities (1-8 x 105 cells per well) in RPMI 1640 with 10% FCS. The medium 
was changed daily after seeding. Cells were harvested 3 days after seeding. (2) 
OLD cells were seeded in 12-well plates at a cell density of 2.5x105 per well in 
RPMI 1640 medium with 10% FCS. After achieving confluence (about 3 days), 
cells were maintained in the same medium for additional 4 days. Cells were 
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harvested at each of the 7-day points. (3) OLD cells were treated in the same 
way as (2) except maintaining confluent cells in 0.25% serum for an additional 4 
days. All the cells were harvested in the same lysis buffer. Protein 
concentration in cell lysate was determined with a SCA micro protein assay kit, 
and each sample containing 15 µg protein was immunoblotted with the antibody 
against CCAF as described previously. 
CCAF gene expression in human colon carcinomas 
Total RNAs from human colon cancer and normal tissues were isolated with a 
TRI REAGENT kit following the instruction of the manufacturer (Sigma, St. Louis, 
MO). The RNA concentration was determined via UV absorbance at 260 nm, 
with 1 OD unit equal to 40 µg/ml RNA. Samples (20 µg RNA) was fractionated 
via electrophoresis in a 1.2% agarose gel containing 2.2 M formaldehyde, and 
electroblotted to a Nytran nylon membrane (Schleicher & Schuell, Keene, NH) 
with a vacuum-blotting system (Pharmacia, Piscataway, NJ). The membrane 
was hybridized with a 32P-labelled CCAF cDNA probe (-2 x 106 cpm) in 5 ml of 
hybridization buffer (250 mM sodium phosphate buffer, pH7.2, 1 mM EDTA, 7% 
SOS and 0.01 % bovine serum albumin) overnight at 68°C in a rotating oven 
(Robbins Scientific, Clayview, CA). After hybridization, the membrane was 
washed at 68°C for 1 hr in hybridization buffer (2 x 30 min) and for 1 hr in 40 mM 
sodium phosphate buffer (pH 7.2, 1 mM EDTA and 1% SOS) (2 x 30 min). An X-
ray film (Sigma Chemical Co, St, Louis, MO) was exposed to the membrane with 
intensifying screen until an appropriate autoradiography was obtained. 
27 
CCAF protein expression in human colon carcinomas 
To compare the CCAF protein expression in human colon cancer to normal 
tissues, homogenates of each sample (15 µg protein), which were provided by 
Dr. Nancy Thomas (Rhode Island Hospital, RI), were size-separated by SDS-
PAGE and immunodetected with the antibody against CCAF as described earlier. 
Determination of CCAF localization 
OLD cells were cultured in 12-well plates in RPMI medium with 10% FCS. When 
reaching confluence, cells were rinsed twice with ice-cold PBS (1 ml/well), and 
detached by a rubber policeman. The cells were collected and centrifuged for 5 
min at 2000 rpm, 4°C. The cell pellet was mixed with 100 µI of NP-40 lysis buffer 
A (10 mM Tris, pH7.4, 10 mM NaCl, 3 mM MgCl2 and 0.5% NP-40) on ice for 5 
min followed by centrifugation at 1000rpm, 4°C for 5 min. The supernatant 
containing cytosol proteins were stored in 0.5 ml plastic tubes while the nuclear 
proteins in the pellet were redissolved in 70 µI of 1 % SDS lysis buffer. All the 
samples prepared above were separated via SOS-PAGE followed by 
immunoblotting with antibody against CCSF as described previously. 
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RESULTS 
CCAF is a 52-KDa protein. 
To establish the molecular weight, CCAF was in vitro translated with TNT 
reticulocyte lysate and analyzed by autoradiography. Addition of the CCAF 
cDNA to the reaction mixture yielded a single product with a molecular weight of 
52-kDa (Fig. 7). This mass is consistent with the estimated weight. In order to 
determine whether CCAF undergoes posttranslational modifications, the CCAF 
cDNA-transfected COS? cell lysates were size-separated via SOS-PAGE and 
analyzed by Coomassie blue assay and Western immunoblotting, respectively. 
As determined by Coomassie blue assay, an extra band with a molecular weight 
of 52-kDa was detected in the CCAF-transfected cells, and the level of the 
protein expression increased with the increase of the CCAF plasmid 
concentration (Fig. 8, lane 2 and 3). An antibody was raised against a peptide 
derived from CCAF and subjected to affinity chromatography. This antibody 
detected the 52-kDa protein in the CCAF cDNA-transfected cells but not in the 
control cells (Fig. 9). Thus, three independent assays all demonstrated that the 
isolated full-length cDNA encodes a protein with a molecular weight of 52-kDa. 
CCAF expression is related to the cell growth states. 
To determine the CCAF expression in different cell growth states, OLD colon 
cancer cells were seeded at different densities, and the cell lysates were 
fractionated via SOS-PAGE and then analyzed by western immunoblotting. As 
shown in Fig. 10, the antibody against CCAF detected a 52-kDa protein in OLD 
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cells at all seeding densities. But the expression of this protein increased with 
the plating densities. The level of this protein in the cells that are seeded at high 
density was -3 to 5-fold higher (lane 3, 4 and 5) than that in the cells that are 
seeded at low density (lane 1 and 2). 
To further confirm this expression pattern, OLD cells were seeded at a certain 
density, and after reaching confluence, cells were maintained in the same 
medium or changed to 0.25% medium for 4 additional days. The expression of 
CCAF was detected at each day point by the same antibody against CCAF. As 
shown in Fig. 11, the CCAF expression was hardly detectable before cell 
reaching confluence (lane1 and 2), while after confluence, the level of CCAF 
protein increased about 3-5 folds (lane 3-6). The level of CCAF expression was 
also positively related to the starvation days (Fig. 12). 
CCAF is abundantly expressed in human colon carcinomas but not in the nearby 
normal tissues. 
Northern blot with the radiolabeled full-length cDNA screened the CCAF mRNA 
expression in various human carcinomas. Except kidney and ovary cancer, 
CCAF gene expression was significantly high in some carcinomas such as lung 
and breast when compared to that in normal tissues (Data not shown). 
Particularly, without exception, this cDNA detected abundant expression of 
CCAF in 5 individual colon cancer cases but not in the nearby normal tissues 
(Fig. 13). The same results were also obtained by using immunoblotting to 
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detect the CCAF protein expression in colon carcinomas. As shown in Fig. 14, 
the antibody specific to CCAF recognized a strong band with a molecular weight 
of 52-kDa in samples from 3 individual colon cancer patients (Lane 3, 4 and 5). 
In contrast, no bands were detected by the same antibody in normal nearby 
tissues (Lane 6 and 7). 
CCAF is localized in cell nucleus. 
DLD cytosol proteins were separated from nuclear proteins, and both were 
subjected to Western immunoblotting analysis. As shown in Fig. 15, the antibody 
against CCAF recognized a protein with a molecular weight of 52-kDa in nucleus 
but not in cytosol, suggesting that the CCAF protein is a nuclear protein. 
CCAF inhibits the transactivation activity of E4 7 on an E-box reporter. 
To test the activity of CCAF on the gene regulation, CCAF plasmids were 
cotransfected with an E-box luciferase reporter and the induction of reporter 
enzyme was determined via a dual-luciferase assay system. As shown in Fig. 
16, E47, a bHLH protein that is known to transactivate E-box reporter, promoted 
a 380-fold increase of luciferase activity. In contrast, CCAF caused little 
activation on luciferase expression by itself, but partially antagonized by 30% the 
enzyme induction conferred by E47. 
31 
Figure 7. In vitro translation 
CCAF was synthesized in vitro via a TNT-coupled reticulocyte lysate system. 
CCAF plasmids (0.5 µg) were added to 25 µI of reaction mixture containing 
reticulocyte lysate, amino acid mixture without methionine, 35S-labeled 
methionine and SP6 polymerase. After 60 min of incubation at 30°C, the 
reaction mixture was chased by adding 625 µM unlabelled methionine (0.5 µI) for 
30 min. To determine the molecular of synthesized CCAF, the mixture (5 µI) was 
denatured in 20 µI of 1X SOS-PAGE sample buffer (31.25 mM Tris-HCI at pH6.8, 
5% glycerol, 0.025% bromophenol blue and 2.5% 2-mercaptoethanol) at 80°C for 
5 min and size-separated via SOS-PAGE. The gel was washed with solution A 
(50% methanol and 10% acetic acid) for 30 min and then solution B (7% 
methanol, 7% acetic acid and 1 % glycerol) for 5 min. The synthesized CCAF 
was detected by autoradiography. 
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Figure 8. Coomassie Blue Assay 
Transfected cell lysate was subjected to SOS-PAGE. The gel was stained for 
half an hour with 0.1% Coomassie blue R-250 in a fixative solution (40% MeOH, 
10% HOAc), destained with 40% MeOH/10% HOAc (1 to 3 hr) to remove the 
background and vacuum-dried on a gel drier. 
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Figure 9. Western immunoblotting 
The transfected cell lysate was subjected to SOS-PAGE. The separated proteins 
were transferred to a nitrocellulose membrane by electroblotting for 1 hr 20 min 
at 36 V, 150 mA in transfer buffer (25 mM Tris, 190 mM glycine, and 20% 
methanol). The membrane was then blocked in 5% non-fat dry milk in TBST ( 10 
mM Tris 8.0, 150 mM NaCl, 0.05% Tween 20) for half an hour, and probed by the 
purified antibody at 1:100 dilution for 1 hr. The membrane was washed three 
times (5-10 min/each) with TBST, and incubated with an alkaline phosphatase-
conjugated anti-rabbit lgG at 1 :5000 dilution for at least 0.5 hr. lmmunoblots 
were developed by color precipitation catalyzed by phosphatase in the presence 
of chromogenic substrates, 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and 
Nitro blue tetrazolium (NBT) in alkline phosphatase buffer (0.1 M Tris, o.1 M NaCl, 
and 5mM MgCl2, pH9.5). 
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Figure 10. CCAF expression at different cell densities 
OLD colon cancer cells were seeded in 12-well plates at various densities ( 1-8 x 
105 cells per well) in RPMI 1640 with 10% FCS. The medium was changed 
everyday after seeding. On days 3 after seeding, cells were harvested in lysis 
buffer. Each sample containing 15 µg protein was analyzed with antibody 
against CCAF. CCAF-transfected COS? cell lysate is also included in this 
experiment. 
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Figure 11. CCAF expression at different cell growth states 
(without changing medium) 
OLD cells were seeded in 12-well plates at a cell density of 2.5x105 per well in 
RPMI 1640 medium with 10% FCS. After achieving confluence (about 3 days), 
cells were maintained in the same media for additional 4 days. At each day 
point, cells were harvested in lysis buffer. Each sample containing 15 µg protein 
was analyzed with antibody against CCAF. 
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Figure 12. CCAF expression at different cell growth states 
(changing to 0.25% FCS) 
OLD cells were seeded in 12-well plates at a cell density of 2.5x105 per well in 
RPMI 1640 medium with 10% FCS. After achieving confluence (about 3 days), 
cells were switched to medium containing 0.25% FCS for additional 4 days. At 
each day point, cells were harvested in the lysis buffer. Each sample containing 
15 µg protein was analyzed by immunoblotting. This figure compared the CCAF 
expression between two days after starvation. 
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Figure 13. CCAF gene expression in human colon carcinomas 
Total RNAs from human colon cancer and normal tissues were isolated with a 
TRI REAGENT kit. Samples (20 µg RNA) was fractionated via electrophoresis in 
a 1.2% agarose gel containing 2.2 M formaldehyde, and blotted to a Nytran nylon 
membrane with a vacuum-blotting system. The membrane was hybridized with a 
32P-labelled CCAF cONA probe (-2 x 106 cpm) in 5 ml of hybridization buffer 
(250 mM sodium phosphate buffer, pH7.2, 1 mM EOTA, 7% SOS and 0.01% 
bovine serum albumin) overnight at 68°C in a rotating oven. After hybridization, 
the membrane was washed at 68°C for 1 hr in hybridization buffer (2 x 30min) 
and for 1 hr in 40 mM sodium phosphate buffer (pH 7 .2, 1 mM EOTA and 1 % 
SOS) (2 x 30 min). CCAF gene expression was visualized by autoradiography. 
The results shown in this figure were obtained from 5 individual patients. 
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Figure 14. CCAF protein expression in human colon carcinomas 
To compare the CCAF protein expression between human colon cancer and 
normal tissues, homogenates of each sample (15 µg protein) were size-
separated by SOS-PAGE and analyzed by immunoblotting. 
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Figure 15. CCAF nuclear localization 
OLD cells were cultured in 12-well plates in RPMI medium with 10% FCS. When 
reaching confluence, cells were rinsed twice with ice-cold PBS (1 ml/well), and 
detached by a rubber policeman. The cells were collected and centrifuged for 5 
min at 2000 rpm, 4°C. Cell pellet was mixed with 100 µI of NP-40 lysis buffer A 
(10 mM Tris, pH7.4, 10 mM NaCl, 3 mM MgCl2 and 0.5% NP-40) on ice for 5 min 
followed by centrifugation at 1000rpm, 4°C for 5 min. The supernatant containing 
cytosol proteins were stored in 0.5 ml plastic tubes while the nuclear proteins in 
the pellet were redissolved in 70 µI of 1 % SOS lysis buffer. All the samples 
prepared above were separated via SOS-PAGE and analyzed by immunoblotting 
with antibody against CCAF. 
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Figure 16. Cotransfection and dual luciferase assay 
E-box-luciferase reporter plasmids (160 ng) was cotransfected with CCAF 
plasmids ( 100 ng) into COS? cells in the presence of lipofectamine following the 
same procedure as described in the Materials and Methods. E47 plasmids (100 
ng) were transfected as a positive control. pRL-TK plasmids (32 ng) encoding 
Renil/a luciferase served as a background control. Transfected cells were 
incubated for 48 hr, rinsed with sodium phosphate buffer twice and lysed in 250 
µI of passive lysis buffer at room temperature for 15 min on a rocking platform. 
The reporter enzyme activities were determined with a Dual-luciferase Reporter 
Assay System via a TD-20/20 luminometer. The Firefly luminescence signal was 
initiated by mixing cell lysate (20 µI) with substrate Luciferase Assay Reagent II 
(LARll, 100 µI). The Renil/a luminescence signal was detected by sequentially 
adding Stop & Glu reagent (100 µI) to the same mixture. The induction of 
reporter enzyme activity was expressed as the ratio of Firefly luminescence 
signal over Renil/a luminescence signal. In this experiment, each group was 
tested in triplicate and repeated once. 
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DISCUSSION 
Basic helix-loop-helix (bHLH) proteins belong to a large family of transcription 
factors that are known to play important roles in cell proliferation, differentiation 
and oncogenesis. These proteins are structurally featured by a bHLH motif, 
which is responsible for protein dimerization and sequence-specific DNA binding 
(e.g., E-box). Recently we isolated a cDNA from a human liver library by a gene 
trapping method. Sequence alignment indicates that this cDNA encodes a 
putative bHLH protein termed CCAF. The objective of this thesis is to establish 
the molecular mass of this protein and to test the hypothesis that CCAF is a 
transcriptional modulator involving the regulation of cell cycle events. 
CCAF is a 52-kDa protein with little posttranslational modifications. 
Based on the Kozak rule, the largest protein encoded by the isolated cDNA is 
415 amino acids long with a calculated molecular mass of 52-kDa. One of the 
studies described in this thesis is to determine the molecular weight of CCAF. 
This is achieved by measuring the mass of CCAF translated in vitro and in CCAF 
cDNA-transfected cells. In both methods, a protein with a molecular weight of 
52-kDa is produced. The consistence with the calculated mass suggests that 
CCAF undergoes little posttranslational modifications. 
CCAF is a cell cycle regulator. 
The expression of CCAF is detected in different cell growing states induced by 
either contact inhibition or serum starvation. The proliferating cells express lower 
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level of CCAF than the growing-arrest cells. This differential expression is 
closely related to the regulation of cell cycle. Myc proteins are highly expressed 
in the proliferating cells but less in the differential cells, and these proteins are 
known to promote the cell proliferation but inhibit the differentiation (Penn et al., 
1990, Chin et al., 1995). The low level of CCAF in the proliferating cells suggests 
that CCAF is a cell cycle regulator, which has little proliferation-promoting activity 
but plays an important role in the rescuing cells from death (anti-apoptotic). 
CCAF has oncogenic significance. 
The expression pattern of CCAF in different cell growing states is similar to the 
oncoprotein junD, which is found to cooperate with ras oncogene in transforming 
rat embryo fibroblast (Vandel L et al., 1996). This similarity suggests that CCAF 
has oncogenic significance. Moreover, abundant CCAF is found in human colon 
carcinomas but not in the nearby tissues. Ectopic and deregulated expression of 
several bHLH proteins is related to oncogenesis. Tal1 and other closely related 
bHLH proteins (Tal2 and L YL 1 ), are normally not expressed in T cells, but are 
constitutively expressed in >60% of T-cell acute lymphoblastic leukemia (T-ALL) 
(Alphan et al., 1992, Bash et al., 1995). In transgenic mice, overexpression of 
TAL 1 gene in cooperation with a misexpressed LM01 protein induces aggressive 
T-cell malignancies (Aplan et al., 1993). 
It has been proposed that the progression of a tumor might not only be a function 
of cell proliferation but also result from inappropriate suppression of apoptosis 
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(Marx, 1993). The oncogenic nature of some bHLH proteins is known to 
suppress apoptosis. For example, TAL 1 bHLH oncoprotein is recently found 
antiapoptotic. A Jurkat leukemic T cell subline expressing a C-terminally 
truncated mutant TAL 1 undergoes rapid apoptosis upon medium depletion. 
Transfection with a wild type of TAL 1 reverses this process, suggesting that 
TAL 1 inhibits the apoptotic signaling in the absence of survival factors (Leroy-
Viard et al., 1995). Overexpression of TAL1 significantly blocks granulopoietic 
and monocytic cell apoptosis induced by chemotherapeutic agents (Bernard et 
al., 1998). The oncogenic pathology of CCAF is likely due to its antiapoptosis. 
CCAF is a gene transcription regulator. 
Not all the proteins that possess bHLH domains are transcription factors. For 
example, the calcium binding proteins with the bHLH domain are just 
components of the calcium-signaling pathway (Marsden et al, 1990). Thus the 
final purpose is to determine if CCAF is a transcription modulator. Firstly, the 
nuclear localization provides the evidence that CCAF is a nuclear protein. Then 
the antagonism of CCAF on E47-mediated transactivation further supports that 
CCAF is a transcription regulator. The molecular mechanisms for such an 
antagonism remain to be determined. There are three hypotheses: (1) CCAF 
binds to the E-box, but the binding doesn't activate transcription; (2) CCAF 
sequestrates E47 by forming inactive, non-DNA-binding heterodimers; (3) CCAF 
dimerizes with E47 but the heterodimers are less active than E47 homodimers. 
E47 is also known a tumor-suppressing protein. The repression on E47 may 
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have oncogenic significance. This has been confirmed in oncoproteins such as 
Tal1, which forms heterodimers with E47 (Steven et al., 1998). 
In summary, the results in the thesis support our overall hypothesis that CCAF is 
a transcriptional modulator involving the regulation of cell cycle events, and the 
expression of CCAF is related to oncogenic pathology. However, further 
experiments need to be conducted to fully understand CCAF from the structure, 
the function and its molecular basis. The electrophoretic gel mobility assay 
(EGMA) can be used to study whether the DNA-binding is required for the 
transcription repression (E-box and/or N-box transactivation). The gene array 
can be used to study the target genes regulated by CCAF, and the yeast two-
hybrid system can be used to study the CCAF mediated protein-protein 
interaction. These studies will likely define whether CCAF is a marker for colon 
tumor diagnosis and whether CCAF is a potential target for the therapeutic 
intervention. 
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APPENDIX ISOLATION OF MULTIPLE DISTINCT cDNAs 
BY A SINGLE CDNA-TRAPPING PROCEDURE 
Maowen Hu and Bingfang Yan 
(Published in 1999, Analytical Biochemistry 266, 233-235) 
Screening of a cDNA library is primarily conducted with nuclei acid hybridization 
or antibody staining. These procedures usually involve library plating, colony 
transferring to a membrane, and clone identification. Because of the high density 
at which clones are plated, isolation of pure clones requires secondary and 
multiple screening at decreasing alone densities. In addition, screening of a 
meaningful number (105-106) of cloned may take weeks or even months 
(Sambrook et al., 1989). 
Recently a cDNA trapping method was developed (Li et al., 1995). In this 
method, a complex population of double-stranded phagemid DNA is isolated 
from a cDNA library and converted to single-stranded DNA (ssDNA). An 
oligonucleotide complementary to a segment of the target cDNA is synthesized 
and biotinylated. The biotin-labeled oligonucleotide is then subjected to 
hybridization with the ssDNAs in solution, and the duplexes are captured on 
streptavidin-coated paramagnetic bead. The captured ssDNAs are then released 
from the beads, repaired with a polymerase, and transformed into bacteria. This 
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method, compared with nucleic acid hybridization and antibody staining, can 
screen a large number of clones and isolate full-length cDNA within days. 
This report describes a modified cDNA trapping procedure, in which several 
oligonucleotides and ssDNAs from more than one library were included in a 
single captured reaction. These oligonucleotides were targeted to distinct 
cDNAs. As a result, full-length cDNAs encoding different proteins were isolated 
by a single trapping procedure. Using this method, we successfully isolated 
several cDNAs encoding different human cytochrome P450 enzymes and 
multiple forms of kinase, which phosphorylate the inositol ring. This modification 
significantly reduces cost and time, which is particularly useful for isolating 
multiple forms of cDNAs. 
Materials and methods. GeneTrapper cDNA kit, human liver and mouse brain 
cDNA libraries, and DH10B Escherichia coli (E. colt) were purchased from 
GibcoBRL (Gaithersburg, MD). All oligonucleotides were synthesized by 
Genemed Synthesis Inc. (South San Franciscon, CA), and their sequences are 
listed in Table 1. Unless otherwise indicated, all other reagents were purchased 
from Sigma (St. Louis, MO). 
The phagemid libraries were grown in 100 ml Luria broth containing 100 µg/ml 
ampicillin with 1 x 106 independent clones to saturation at 30°C (-16h). The 
bacterial cells were then centrifuged at 4800g for 15 min at 4°C. The pellet was 
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resuspended in 10 ml buffer I containing 15 mM Tris-HCI (pH8.0), 10 mM EDTA, 
RNase A (100 µg/ml), and RNase T1 (1200 units/ml). Bacterial cells were lysed 
by adding 10 ml buffer II containing 0.2 M Na OH and 1 % SOS. The solution was 
then neutralized by adding 10 ml of ice-cold 7.5 M NH40ac, mixed gently by 
inverting the tubes five times, and incubated on ice for 10 min. The supernatant 
was prepared by centrifuging at 3000g for 15 min at 4C and filtered through 
cheesecloth. Phagemid DNA was then precipitated by adding an equal amount 
of cold isopropanol and centrifuging at 5000g for 15 min at 4C. The DNA pellet 
was resuspended in 1 ml buffer I and centrifuged at 12,000g for 1 min at 4C. 
The DNA sample was incubated at 37C for 15 min and extracted with an equal 
volume of phenol:chloroform:isoamyl alcohol (25:24:1) four times. The phagemid 
DNA in the aqueous phase was mixed with an equal volume of isopropanol 
followed by centrifugation at 14,000g for 15 min at 4°C. The pellet was then 
washed once with 500 µI of 70% ethanol and left to air dry for 15 min at room 
temperature. The DNA was then dissolved in 200 µI TE buffer [10 mM Tris-HCI 
(pH8.0), 1 mM EDTA] and stored at -29°C until use. 
Two groups with a total of six oligonucleotides were synthesized (Table1 ): one 
group (P450 group) was targeted to human cytochrome P4502C8, P4502E 1, and 
P45 reductase, respectively; and the other group (kinase group) was targeted to 
mouse type I phosphatidylinoditol 4-phosphate 5-kinases (Pl4P5 kinase), a and f3 
and human inositol 1,3,4-trisphosphate 5/6-kinase [Ins (1,3,4) P3 5/6-kinase], 
respectively. Oligonucleotides were purified by 16% polyacrylamide gel 
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electrophoresis (Vorndam et al., 1986). The oligonucleotides (1 µg each) in the 
same group were then mixed and biotinylated in a total volume of 25 µI with 
biotin-14-dCTP and terminal deoxynucleotidyl transferase as described by the 
manufacturer. 
Double-stranded phagemid DNA was converted to ssDNA by a sequential 
digestion with Gene II and Exolll, and the ssDNA was denatured at 95C for 1 min 
and chilled in ice for 1 min. Hybridization between the ssDNA and biotinylated 
oligonucleotides was conducted at 37°C for 1 h with the hybridization buffer 
provided by the manufacturer. One hybridization reaction was conducted with 
the biotinylated oligonucleotides (20 ng) from the P450 group and the ssDNAs 
(2.5 µg) from the human liver library, whereas the other hybridization was 
conducted with the biotinylated oligonucleotides (20 ng) from the kinase group 
and a mixture of the ssDNAs from both the human liver and mouse brain libraries 
(1.25 µg each). The hybridized ssDNAs were repaired by a thermostable 
polymerase. 
manufacturer. 
These procedures were conducted as described by the 
The repaired captured DNAs (-20% of total) were used to transform DH10B E. 
coli (23 µI) with a Cell Porator electroporation system at a field strength of 16.6 
kV/cm and a pulse length of 4 ms (GibcoBRL, Gaithersburg, MD). The 
electroporated cells were incubated at 37°C overnight. Individual colonies were 
grown in 5 ml of Lauri broth, the phagemid DNA was isolated with a QIAprep 
68 
Spin Miniprep kit (QIAGEN Inc., Santa Clarita, CA) and sequences of the 
captured DNAs were determined with an EXCEL II DNA sequencing kit from 
Epicentre Technologies (Madison, WI) as described previously (Yan et al., 1995). 
Results and discussion. Oligonucleotides in the P450 group were targeted to 
human cytochrome P4502C8, P4502E1, and P450 reductase, respectively. 
They were designed to anneal to the 5'-coding region of each cDNA. The 
trapping experiment with these oligonucleotides results in the isolation of -500 
individual clones. From those, 32 individual clones were cultured and the 
corresponding phagemid DNAs were isolated. Sequencing of the 5'-end (-350 
bases long) demonstrated that they all contained full-length cDNA inserts. 
Among them, 6 clones contained the cDNA encoding P4502C8, 4 clones 
contained the cDNA encoding P4502C18, and 16 clones contained the cDNA 
encoding P4502E1, as shown in Table 2. Therefore, half of the sequenced 
clones contained the cDNA encoding P4502E1. 
The P4502C subfamily has four members: they are used in this experiment for 
this subfamily matched the sequence of 2C8 perfectly, but did not match the 
sequence of 2C9, 2C18, or 2C19 by two bases. As expected, the trapping 
experiment isolated the cDNA encoding 2C8. However, surprisingly the trapping 
experiment also isolated the cDNA encoding 2C18 but not 2C9 and 2C19. The 
reason for this phenomenon was probably due to the relative abundance of the 
cDNA in this library. Namely, the cDNA encoding 2C18 was more abundant in 
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this library than those encoding either 2C9 or 2C19. Similarly, a relatively high 
abundance of 2E1 cDNA in the library was probably the reason that 50% of the 
clones sequenced in the P450 group contained the cDNA encoding this enzyme. 
Compared with other P45 enzymes, P4502E1 is not a very abundant enzyme in 
normal liver (only -9% of total P450). However, the level of P4502E1 can be 
significantly increased by environmental factors such as alcohol consumption 
and disease status such as diabetes. It is likely that the individual whose liver 
mRNA was used for the constriction of this library was previously exposed to one 
or more of these factors. 
In contrast, the trapping experiment with the oligonucleotides in kinase group 
yielded only 31 individual clones. As shown in Table 3, 2 of these clones 
encoded mouse type I Pl4/5-kinase a; 6 of them encoded mouse type I Pl4/5-
kinase 13; 4 of them encoded a recently identified type I Pl4P5-kinase, termed y; 
and 7 of them encoded human Ins (1,3,4) P3 5/6-kinase. The rest of these 
clones encoded other proteins. Form y exhibits a high degree of sequence 
identity (20 of 21 bases) with form 13 in the region where the oligonucleotide was 
derived. Thus, the cDNA encoding form y was probably captured by the 
oligonucleotide for form 13. It should be noted that the human liver and mouse 
brain libraries were constructed with vectors that have different flanking 
sequences at the polylinker region, which was used to establish by the 
polymerase chain reaction which library was the source from which a cDNA was 
isolated. 
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Among the cONAs encoding other proteins in the kinase group, half coded for 
vitamin 0-binding protein (Table 3), and the rest apparently coded for yet 
unidentified proteins based on a BLST search in Gene Bank. These unidentified 
proteins may actually share a significant sequence identity with the 
oligonucleotides used for the trapping experiment (only a -350-bp sequence in 
the 5' end was determined), which probably contributed to their isolated. In 
contrast, the cONA encoding vitamin 0-binding protein shows no significant 
sequence identity with the oligonucleotides; the reason for its isolation remains to 
be determined. It was likely that the abundance of the cONAs coding for the 
kinases to be isolated in these libraries was so low that an excess of the labeled 
oligonucleotides was available to hybridize with unrelated cONAs and yields false 
positives. This notion if supported by the fact that all of the sequenced clones in 
the P450 trapping experiment resulted in the isolation of target cONAs, because 
P450 enzymes, the primary phase I drug-metabolizing enzymes, are very 
abundant in the liver (Shephard et al., 1992). 
We report here a modified cONA trapping technique that can accommodate 
multiple oligonucleotides and more than one library at the same time. This 
method has all the features of the original method such as screening of a large 
number of clones within a week, rapid isolation of full-length cONA, and 
identification of related sequences. This modified method, compared with the 
original method, saves time and significantly reduces the cost, as the reagent 
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used for cDNA trapping are expensive. This is particularly effective for isolating 
multiple forms of cDNAs. 
Table 5. Sequence of oligonucleotides for cDNA trapping 
Enzyme Sequence Reference 
Human cytochrome P4502C8 5'-gtc tat ggt cct gtg ttc acc-3' 5 
Human cytochrome P4502E1 5'-gtg gtg atg cac ggc tac aag-3' 11 
Human cytochrome P450 reductase 5'-cag cat gac ggc cat gat tct-3' 12 
Mouse Pl-4-phosphat 5-kinase a 5'-caa tgg gag gca ttc cag cta-3' 8 
Mouse Pl-4-phosphate 5-kinase p 5'-caa gac eta tgc ace tgt tgc-3' 9 
Inositol 1,3,4-triphosphate 5/6-kinase 5'-atc ate cac aag ctg act gac-3' 10 
Table 6. cDNA trapping of human cytochrome P450 enzymes and reductase 
Enzyme 
P4502C8 
P4502C18 
P4502E1 
P450 reductase 
Number of positive clones 
6 
4 
16 
6 
% of clones sequenced 
19 
13 
50 
18 
Table 7. cDNA trapping of Pl-4-phospate 5-kinse and 
inositol 1,3,4-triphosphate 5/6-kinase 
Enzyme Number of positive clones 
Mouse Pl-4-phosphat 5-kinase a 2 
Mouse Pl-4-phosphate 5-kinase p 6 
Mouse Pl-4-phosphate 5-kinase y 4 
Inositol 1,3,4-triphosphate 5/6-kinase 7 
Others 12 
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% of clones sequenced 
6 
20 
13 
23 
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